Arcus biosciences to participate in two upcoming investor conferences

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following upcoming investor conferences in september: morgan stanley 22nd annual global healthcare conference date: wednesday, september 4th, 2024 at 4:55 p.m. et location: new york, ny format: fireside chat cantor fitzgerald g.
RCUS Ratings Summary
RCUS Quant Ranking